14-3-3 proteins play a role in the cell cycle by shielding Cdt2 from ubiquitin-mediated degradation

Molecular and Cellular Biology

Volumn 34, Issue 21, 2014, Pages 4049-4061

  Dar, Ashraf ^a   Wu, David ^a   Lee, Nicholas ^a   Shibata, Etsuko ^a   Dutta, Anindya ^a  

^a UNIVERSITY OF VIRGINIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CDT2 PROTEIN; METHYLTRANSFERASE; PROTEASOME; PROTEIN; PROTEIN 14 3 3; THREONINE; UBIQUITIN; UBIQUITIN PROTEIN LIGASE E3; UNCLASSIFIED DRUG; DTL PROTEIN, HUMAN; F BOX PROTEIN; FBXO11 PROTEIN, HUMAN; NUCLEAR PROTEIN; PROTEIN ARGININE METHYLTRANSFERASE; UBIQUITIN PROTEIN LIGASE;

ARTICLE; CELL CYCLE; CELL CYCLE G2 PHASE; CELL CYCLE M PHASE; CELL CYCLE PROGRESSION; CELL PROLIFERATION; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME DEGRADATION; FEMALE; GENE MUTATION; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; PROTEIN DEGRADATION; PROTEIN DEPLETION; PROTEIN PHOSPHORYLATION; PROTEIN PROTEIN INTERACTION; UBIQUITINATION; BINDING SITE; GENETICS; HALF LIFE TIME; HEK293 CELL LINE; HELA CELL LINE; METABOLISM; PHOSPHORYLATION;

14-3-3 PROTEINS; BINDING SITES; CELL CYCLE; F-BOX PROTEINS; HALF-LIFE; HEK293 CELLS; HELA CELLS; HUMANS; NUCLEAR PROTEINS; PHOSPHORYLATION; PROTEASOME ENDOPEPTIDASE COMPLEX; PROTEIN-ARGININE N-METHYLTRANSFERASES; THREONINE; UBIQUITIN-PROTEIN LIGASES; UBIQUITINATION;

EID: 84907857808     PISSN: 02707306     EISSN: 10985549     Source Type: Journal    
DOI: 10.1128/MCB.00838-14     Document Type: Article

References (43)

1. Teixeira LK, Reed SI. 2013. Ubiquitin ligases and cell cycle control. Annu. Rev. Biochem. 82:387-414. http://dx.doi.org/10.1146/annurev-biochem -060410-105307.
2. Deshaies RJ, Joazeiro CA. 2009. RING domain E3 ubiquitin ligases. Annu. Rev. Biochem. 78:399-434. http://dx.doi.org/10.1146/annurev.biochem.78.101807.093809.
3. Hua Z, Vierstra RD. 2011. The cullin-RING ubiquitin-protein ligases. Annu. Rev. Plant Biol. 62:299-334. http://dx.doi.org/10.1146/annurev -arplant-042809-112256.
4. Havens CG, Walter JC. 2011. Mechanism of CRL4(Cdt2), a PCNAdependent E3 ubiquitin ligase. Genes Dev. 25:1568-1582. http://dx.doi.org/10.1101/gad.2068611.
5. Abbas T, Shibata E, Park J, Jha S, Karnani N, Dutta A. 2010. CRL4(Cdt2) regulates cell proliferation and histone gene expression by targeting PR-Set7/Set8 for degradation. Mol. Cell 40:9-21. http://dx.doi.org/10.1016/j.molcel.2010.09.014.
6. Abbas T, Sivaprasad U, Terai K, Amador V, Pagano M, Dutta A. 2008. PCNA-dependent regulation of p21 ubiquitylation and degradation via the CRL4Cdt2 ubiquitin ligase complex. Genes Dev. 22:2496-2506. http: //dx.doi.org/10.1101/gad.1676108.
7. Arias EE, Walter JC. 2006. PCNA functions as a molecular platform to trigger Cdt1 destruction and prevent re-replication. Nat. Cell Biol. 8:84-http://dx.doi.org/10.1038/ncb1346.
8. Centore RC, Havens CG, Manning AL, Li JM, Flynn RL, Tse A, Jin J, Dyson NJ, Walter JC, Zou L. 2010. CRL4(Cdt2)-mediated destruction of the histone methyltransferase Set8 prevents premature chromatin compaction in S phase. Mol. Cell 40:22-33. http://dx.doi.org/10.1016/j.molcel.2010.09.015.
9. Clijsters L, Wolthuis R. 2014. PIP-box-mediated degradation prohibits re-accumulation of Cdc6 during S phase. J. Cell Sci. 127:1336-1345. http: //dx.doi.org/10.1242/jcs.145862.
10. Hall JR, Lee HO, Bunker BD, Dorn ES, Rogers GC, Duronio RJ, Cook JG. 2008. Cdt1 and Cdc6 are destabilized by rereplication-induced DNA damage. J. Biol. Chem. 283:25356-25363. http://dx.doi.org/10.1074/jbc.M802667200.
11. Kim Y, Starostina NG, Kipreos ET. 2008. The CRL4Cdt2 ubiquitin ligase targets the degradation of p21Cip1 to control replication licensing. Genes Dev. 22:2507-2519. http://dx.doi.org/10.1101/gad.1703708.
12. Senga T, Sivaprasad U, Zhu W, Park JH, Arias EE, Walter JC, Dutta A. 2006. PCNA is a cofactor for Cdt1 degradation by CUL4/DDB1-mediated N-terminal ubiquitination. J. Biol. Chem. 281:6246-6252. http://dx.doi.org/10.1074/jbc.M512705200.
13. Liu CL, Yu IS, Pan HW, Lin SW, Hsu HC. 2007. L2dtl is essential for cell survival and nuclear division in early mouse embryonic development. J. Biol. Chem. 282:1109-1118. http://dx.doi.org/10.1074/jbc.M606535200.
14. Mackintosh C, Ordonez JL, Garcia-Dominguez DJ, Sevillano V, Llombart-Bosch A, Szuhai K, Scotlandi K, Alberghini M, Sciot R, Sinnaeve F, Hogendoorn PC, Picci P, Knuutila S, Dirksen U, Debiec-Rychter M, Schaefer KL, de Alava E. 2012. 1q gain and CDT2 overexpression underlie an aggressive and highly proliferative form of Ewing sarcoma. Oncogene 31:1287-1298. http://dx.doi.org/10.1038/onc.2011.317.
15. Baraniskin A, Birkenkamp-Demtroder K, Maghnouj A, Zollner H, Munding J, Klein-Scory S, Reinacher-Schick A, Schwarte-Waldhoff I, Schmiegel W, Hahn SA. 2012. MiR-30a-5p suppresses tumor growth in colon carcinoma by targeting DTL. Carcinogenesis 33:732-739. http://dx.doi.org/10.1093/carcin/bgs020.
16. Li J, Ng EK, Ng YP, Wong CY, Yu J, Jin H, Cheng VY, Go MY, Cheung PK, Ebert MP, Tong J, To KF, Chan FK, Sung JJ, Ip NY, Leung WK. 2009. Identification of retinoic acid-regulated nuclear matrix-associated protein as a novel regulator of gastric cancer. Br. J. Cancer 101:691-698. http://dx.doi.org/10.1038/sj.bjc.6605202.
17. Pan HW, Chou HY, Liu SH, Peng SY, Liu CL, Hsu HC. 2006. Role of L2DTL, cell cycle-regulated nuclear and centrosome protein, in aggressive hepatocellular carcinoma. Cell Cycle 5:2676-2687. http://dx.doi.org/10.4161/cc.5.22.3500.
18. Ueki T, Nishidate T, Park JH, Lin ML, Shimo A, Hirata K, Nakamura Y, Katagiri T. 2008. Involvement of elevated expression of multiple cellcycle regulator, DTL/RAMP (denticleless/RA-regulated nuclear matrix associated protein), in the growth of breast cancer cells. Oncogene 27: 5672-5683. http://dx.doi.org/10.1038/onc.2008.186.
19. Lin JJ, Milhollen MA, Smith PG, Narayanan U, Dutta A. 2010. NEDD8-targeting drug MLN4924 elicitsDNArereplication by stabilizing Cdt1 in S phase, triggering checkpoint activation, apoptosis, and senescence in cancer cells. Cancer Res. 70:10310-10320. http://dx.doi.org/10.1158/0008 -5472.CAN-10-2062.
20. Lydeard JR, Schulman BA, Harper JW. 2013. Building and remodelling Cullin-RING E3 ubiquitin ligases. EMBO Rep. 14:1050-1061. http://dx.doi.org/10.1038/embor.2013.173.
21. Soucy TA, Smith PG, Milhollen MA, Berger AJ, Gavin JM, Adhikari S, Brownell JE, Burke KE, Cardin DP, Critchley S, Cullis CA, Doucette A, Garnsey JJ, Gaulin JL, Gershman RE, Lublinsky AR, McDonald A, Mizutani H, Narayanan U, Olhava EJ, Peluso S, Rezaei M, Sintchak MD, Talreja T, Thomas MP, Traore T, Vyskocil S, Weatherhead GS, Yu J, Zhang J, Dick LR, Claiborne CF, Rolfe M, Bolen JB, Langston SP. 2009. An inhibitor of NEDD8-activating enzyme as a new approach to treat cancer. Nature 458: 732-736. http://dx.doi.org/10.1038/nature07884.
22. Ishii T, Shiomi Y, Takami T, Murakami Y, Ohnishi N, Nishitani H. 2010. Proliferating cell nuclear antigen-dependent rapid recruitment of Cdt1 and CRL4Cdt2 at DNA-damaged sites after UV irradiation in HeLa cells. J. Biol. Chem. 285:41993-42000. http://dx.doi.org/10.1074/jbc.M110.161661.
23. Abbas T, Mueller AC, Shibata E, Keaton M, Rossi M, Dutta A. 2013. CRL1-FBXO11 promotes Cdt2 ubiquitylation and degradation and regulates Pr-Set7/Set8-mediated cellular migration. Mol. Cell 49:1147-1158. http://dx.doi.org/10.1016/j.molcel.2013.02.003.
24. Rossi M, Duan S, Jeong YT, Horn M, Saraf A, Florens L, Washburn MP, Antebi A, Pagano M. 2013. Regulation of the CRL4(Cdt2) ubiquitin ligase and cell-cycle exit by the SCF(Fbxo11) ubiquitin ligase. Mol. Cell 49:1159-1166. http://dx.doi.org/10.1016/j.molcel.2013.02.004.
25. Hermeking H. 2003. The 14-3-3 cancer connection. Nat. Rev. Cancer 3:931-943. http://dx.doi.org/10.1038/nrc1230.
26. Reinhardt HC, Yaffe MB. 2013. Phospho-Ser/Thr-binding domains: navigating the cell cycle and DNA damage response. Nat. Rev. Mol. Cell Biol. 14:563-580. http://dx.doi.org/10.1038/nrm3640.
27. Hermeking H, Benzinger A. 2006. 14-3-3 proteins in cell cycle regulation. Semin. Cancer Biol. 16:183-192. http://dx.doi.org/10.1016/j.semcancer.2006.03.002.
28. Margolis SS, Perry JA, Forester CM, Nutt LK, Guo Y, Jardim MJ, Thomenius MJ, Freel CD, Darbandi R, Ahn JH, Arroyo JD, Wang XF, Shenolikar S, Nairn AC, Dunphy WG, Hahn WC, Virshup DM, Kornbluth S. 2006. Role for the PP2A/B56delta phosphatase in regulating 14-3-3 release from Cdc25 to control mitosis. Cell 127:759-773. http://dx.doi.org/10.1016/j.cell.2006.10.035.
29. Shibata E, Dar A, Dutta A. 2014. CRL4Cdt2 E3 ubiquitin ligase and proliferating cell nuclear antigen (PCNA) cooperate to degrade thymine DNA glycosylase in S phase. J. Biol. Chem. 289:23056-23064. http://dx.doi.org/10.1074/jbc.M114.574210.
30. Dar A, Shibata E, Dutta A. 2013. Deubiquitination of Tip60 by USP7 determines the activity of the p53-dependent apoptotic pathway. Mol. Cell. Biol. 33:3309-3320. http://dx.doi.org/10.1128/MCB.00358-13.
31. Kim Y, Kipreos ET. 2007. Cdt1 degradation to prevent DNA rereplication: conserved and non-conserved pathways. Cell Div. 2:18. http: //dx.doi.org/10.1186/1747-1028-2-18.
32. Takeda DY, Parvin JD, Dutta A. 2005. Degradation of Cdt1 during S phase is Skp2-independent and is required for efficient progression of mammalian cells through S phase. J. Biol. Chem. 280:23416-23423. http: //dx.doi.org/10.1074/jbc.M501208200.
33. Oda H, Okamoto I, Murphy N, Chu J, Price SM, Shen MM, Torres-Padilla ME, Heard E, Reinberg D. 2009. Monomethylation of histone H4-lysine 20 is involved in chromosome structure and stability and is essential for mouse development. Mol. Cell. Biol. 29:2278-2295. http://dx.doi.org/10.1128/MCB.01768-08.
34. Jorgensen S, Eskildsen M, Fugger K, Hansen L, Larsen MS, Kousholt AN, Syljuasen RG, Trelle MB, Jensen ON, Helin K, Sorensen CS. 2011. SET8 is degraded via PCNA-coupled CRL4(CDT2) ubiquitylation in S phase and after UV irradiation. J. Cell Biol. 192:43-54. http://dx.doi.org /10.1083/jcb.201009076.
35. Abbas T, Dutta A. 2009. p21 in cancer: intricate networks and multiple activities. Nat. Rev. Cancer 9:400-414. http://dx.doi.org/10.1038/nrc2657.
36. Arias EE, Walter JC. 2005. Replication-dependent destruction of Cdt1 limits DNA replication to a single round per cell cycle in Xenopus egg extracts. Genes Dev. 19:114-126. http://dx.doi.org/10.1101/gad.1255805.
37. Henriksson ML, Francis MS, Peden A, Aili M, Stefansson K, Palmer R, Aitken A, Hallberg B. 2002. A nonphosphorylated 14-3-3 binding motif on exoenzyme S that is functional in vivo. Eur. J. Biochem. 269:4921- 4929. http://dx.doi.org/10.1046/j.1432-1033.2002.03191.x.
38. Zhang L, Wang H, Liu D, Liddington R, Fu H. 1997. Raf-1 kinase and exoenzyme S interact with 14-3-3zeta through a common site involving lysine 49. J. Biol. Chem. 272:13717-13724. http://dx.doi.org/10.1074/jbc.272.21.13717.
39. Steinacker P, Schwarz P, Reim K, Brechlin P, Jahn O, Kratzin H, Aitken A, Wiltfang J, Aguzzi A, Bahn E, Baxter HC, Brose N, Otto M. 2005. Unchanged survival rates of 14-3-3gamma knockout mice after inoculation with pathological prion protein. Mol. Cell. Biol. 25:1339-1346. http: //dx.doi.org/10.1128/MCB.25.4.1339-1346.2005.
40. Alabert C, Bukowski-Wills JC, Lee SB, Kustatscher G, Nakamura K, de Lima Alves F, Menard P, Mejlvang J, Rappsilber J, Groth A. 2014. Nascent chromatin capture proteomics determines chromatin dynamics during DNA replication and identifies unknown fork components. Nat. Cell Biol. 16:281-293. http://dx.doi.org/10.1038/ncb2918.
41. Simboeck E, Sawicka A, Zupkovitz G, Senese S, Winter S, Dequiedt F, Ogris E, Di Croce L, Chiocca S, Seiser C. 2010. A phosphorylation switch regulates the transcriptional activation of cell cycle regulator p21 by histone deacetylase inhibitors. J. Biol. Chem. 285:41062-41073. http://dx.doi.org/10.1074/jbc.M110.184481.
42. Jin YH, Kim YJ, Kim DW, Baek KH, Kang BY, Yeo CY, Lee KY. 2008. Sirt2 interacts with 14-3-3beta/gamma and down-regulates the activity of p53. Biochem. Biophys. Res. Commun. 368:690-695. http://dx.doi.org /10.1016/j.bbrc.2008.01.114.
43. Ajjappala BS, Kim YS, Kim MS, Lee MY, Lee KY, Ki HY, Cha DH, Baek KH. 2009. 14-3-3 gamma is stimulated by IL-3 and promotes cell proliferation. J. Immunol. 182:1050-1060. http://dx.doi.org/10.4049/jimmunol.182.2.1050.